What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Surgery and Randomized controlled trial.
His study in Meta-analysis, Odds ratio, Coronary artery disease, Confidence interval and Stroke falls under the purview of Internal medicine.
His Subgroup analysis study in the realm of Meta-analysis interacts with subjects such as In patient.
His Myocardial infarction study incorporates themes from Clinical endpoint and Interquartile range.
His work carried out in the field of Surgery brings together such families of science as Angioplasty, Inclusion and exclusion criteria and Revascularization.
His Randomized controlled trial research integrates issues from Standard treatment, Anesthesia, Clinical trial and MEDLINE.
His most cited work include:
- Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. (819 citations)
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. (792 citations)
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis (759 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Surgery, Myocardial infarction and Percutaneous coronary intervention.
His Internal medicine and Coronary artery disease, Conventional PCI, Randomized controlled trial, Stent and Meta-analysis investigations all form part of his Internal medicine research activities.
His work in Randomized controlled trial covers topics such as Anesthesia which are related to areas like Cardiac surgery.
In general Cardiology study, his work on Revascularization, Heart failure and Mace often relates to the realm of In patient, thereby connecting several areas of interest.
His research integrates issues of Stenosis and Angioplasty in his study of Surgery.
His studies deal with areas such as Artery, Clinical endpoint, Disease and Hazard ratio as well as Myocardial infarction.
He most often published in these fields:
- Internal medicine (59.25%)
- Cardiology (51.12%)
- Surgery (28.86%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (59.25%)
- Cardiology (51.12%)
- Myocardial infarction (27.56%)
In recent papers he was focusing on the following fields of study:
Giuseppe Biondi-Zoccai spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Randomized controlled trial and Meta-analysis.
Cardiology and In patient are two areas of study in which he engages in interdisciplinary research.
His work deals with themes such as Adverse effect, Disease, Incidence and Propensity score matching, which intersect with Myocardial infarction.
Giuseppe Biondi-Zoccai usually deals with Randomized controlled trial and limits it to topics linked to Intensive care medicine and Severe acute respiratory syndrome coronavirus 2 and Coronavirus disease 2019.
His Meta-analysis research includes themes of Observational study, Systematic review, MEDLINE, Relative risk and Protocol.
The various areas that Giuseppe Biondi-Zoccai examines in his Percutaneous coronary intervention study include Stent and Surgery.
Between 2017 and 2021, his most popular works were:
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. (792 citations)
- Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery (206 citations)
- European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. (91 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
Internal medicine, Myocardial infarction, Cardiology, Randomized controlled trial and Percutaneous coronary intervention are his primary areas of study.
His work deals with themes such as Stroke, Disease and Hazard ratio, which intersect with Myocardial infarction.
His research integrates issues of Adverse effect and Clinical trial in his study of Cardiology.
His study in the field of Intention-to-treat analysis also crosses realms of Treatment effect.
His Percutaneous coronary intervention study incorporates themes from Interventional cardiology, Conventional PCI and Emergency medicine.
His work carried out in the field of Coronary artery disease brings together such families of science as Cochrane Library, Surgery, Radiology, Angioplasty and Lower risk.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
